Assessing the efficacy and website safety for novel drug candidates for Alzheimer's disease employs a rigorous evaluation framework. Preclinical studies typically involve in vitro and in vivo models to assess a potential ability in targeting disease-related pathways. Once promising candidates emerge, they enter clinical trials that are conducted i